A meeting between President Trump and the pharmaceutical industry was called off Tuesday in the wake of his newly signed executive orders on drug prices. Trump signed four orders, including easing rules on drug imports from Canada and lowering the cost of insulin for some Americans. In a new... Read more
For several days now, an anti-malarial drug has been touted by President Trump and others as a promising treatment for COVID-19. The FDA, which has approved hydroxychloroquine and chloroquine as a treatment for malaria, lupus and rheumatoid arthritis, issued an emergency order recently allowing physicians to administer them to... Read more
“Corporate greed.’’ “Steering patients.’’ “No transparency.’’ Those phrases were used by Georgia lawmakers Thursday to characterize the complicated practices of pharmacy benefit managers. PBMs basically are corporate middlemen between health insurers or large employers and drugmakers in handling pharmaceutical benefits. A trio of House bills aim to strengthen regulation and... Read more
PBMs: Power brokers in the prescription drug world
FeatureReader Favorites February 10, 2020 0
A recent legislative hearing in Atlanta featured a stream of PBM critics. South Georgia pharmacist Nikki Bryant said PBMs are putting her out of business. Cancer patient Katie Groover said they have “exhausting” bureaucratic processes that “take away patient choice.’’ Dr. Melissa Dillmon, a Rome oncologist, said PBMs often cause... Read more
Stopping the COVID spread
Jul 24, 2020 0
The reopening of Georgia
May 11, 2020 0
A crucial moment for the state
Mar 24, 2020 0
Trump’s plan on pharmaceuticals needs support
Commentary July 28, 2020 1